Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

MabThera/Rituxan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.

Roche appoints Thomas Schinecker as new chief executive officer

Roche appoints Thomas Schinecker as new chief executive officer

caused by cheap biotechnology copies of well-known oncology medicines like Herceptin, Avastin and Rituxan, that once accounted for about 50% of drug sales.

Amgen’s Riabni combination granted FDA approval for rheumatoid arthritis

Amgen’s Riabni combination granted FDA approval for rheumatoid arthritis The combination of Riabni, a biosimilar for Rituxan, with methotrexate is specifically for adult RA patients who have had one or more unsuccessful prior treatments. ... It is also not indicated for use in adult patients with moderate to severe pemphigus

Roche’s Polivy receives EC approval for lymphoma therapy

Roche’s Polivy receives EC approval for lymphoma therapy Polivy (polatuzumab vedotin) in combination with MabThera.

Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting

Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting The company released topline results of the study in August. In the study, Roche’s Polivy added to MabThera/Rituxanplus chemotherapy went head-to-head with the standard-of-care regimen ... called R-CHOP (MabThera/Rituxan, cyclophosphamide, doxorubicin,

Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues

Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues The specific impact of biosimilars on Roche’s MabThera/Rituxan, Avastin and Herceptin franchises remained ‘significant’, particularly in the US.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....